Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years

Rheumatology International

Volumn 32, Issue 9, 2012, Pages 2701-2705

  Kiani, Adnan K ^a   Petri, Michelle ^a   Magder, Laurence S ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Atherosclerosis; Mycophenolate mofetil; Systemic lupus erythematosus

Indexed keywords

CALCIUM; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AFRICAN AMERICAN; ANTIINFLAMMATORY ACTIVITY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADULT; CALCIUM; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84866410515     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2048-y     Document Type: Article

References (38)

1. Moder KG (2003) Mycophenolate mofetil: new applications for this immunosuppressant. Ann Allergy Asthma Immunol 90:15-19
2. Allison A, Eugui E (1993) Immunosuppressive and other Effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 136:5-28 (Pubitemid 24033096)
3. Richter MH, Zahn S, Kraus M, Mohr FW, Olbrich HG (2003) Mycophenolate mofetil signiWcantly reduces leukocyte graft inWltration after heterotopic cardiac transplantation in a rat model: comparative study with cyclosporine and FK 506. J Heart Lung Transplant 22:1107-1116 (Pubitemid 37206566)
4. Jonsson CA, Erlandsson M, Svensson L, Molne J, Carlsten H (1999) Mycophenolate mofetil ameliorates perivascular T lymphocyte inXammation and reduces the double-negative T cell population in SLE prone MRLlpr/lpr mice. Cell Immunol 197:136-144 (Pubitemid 30000734)
5. Laurent AF, Dumont S, Poindron P, Muller CD (1996) Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endothelial cells and to some substrates. Exp Hematol 24:59-67 (Pubitemid 26041775)
6. Chan TM, Li FK, Tang CSO, Wong RWS, Fang GX et al (2000) EYcacy of mycophenolate mofetil in patients with diVuse proliferative lupus nephritis. N Engl J Med 343:1156-1162
7. Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E (2004) Sequential therapies for lupus nephritis. N Engl J Med 350:971-980
8. Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353:2219-2228 (Pubitemid 41697285)
9. Dansky HM, Barlow CB, Lominska C, Sikes JL, Kao C, Weinsaft J (2001) Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler Thromb Vasc Biol 21:1662-1667 (Pubitemid 34215588)
10. Bourdillon MC, Poston RN, Covacho C, Chignier E, Bricca G, McGregor JL (2000) ICAM-1 deWciency reduces atherosclerotic lesions in double-knockout mice (ApoE/ICAM-1) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol 20:2630-2635
11. Laurent AF, Dumont S, Poindron P, Muller CD (1996) Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endothelial cells and to some substrates. Exp Hematol 24:59-67 (Pubitemid 26041775)
12. Shimizu H, Takahashi M, Takeda S, Inoue S, Fujishiro J, Hakamata Y (2004) Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation. Transplantation 77:1661-1667 (Pubitemid 38780531)
13. Gregory CR, Pratt RE, Huie P, Shorthouse R, Dzau VJ, Billingham ME (1993) Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. Transplant Proc 25:770-771 (Pubitemid 23082553)
14. Eisen HJ, Kobashigawa J, Keogh A (2005) Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant 24:517-525 (Pubitemid 40693872)
15. Pethig K, Heublein B, Wahlers T (2004) Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: inXuence on inXammation and progression of intimal hyperplasia. J Heart Lung Transplant 23:61-66 (Pubitemid 38088020)
16. Ward MM (1999) Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 42:338-346 (Pubitemid 29072852)
17. Gladman DD, Urowitz MB (1987) Morbidity in systemic lupus erythematosus. J Rheumatol 14:223-226
18. Manzi S, Meilahn EN, Rairie JE (1997) Age-speciWc incidence rates of myocardial infarction and angina in women with SLE: comparison with the Framingham Study. Am J Epidemiol 145:408-415 (Pubitemid 27084212)
19. Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513-519
20. BudoV MJ, Achenbach S, Blumenthal RS, Goldin JG, Rader DJ (2006) Assessment of coronary artery disease by cardiac computed tomography. Circulation 114:1761-1791
21. Detrano R, Tzung H, Wang S (1996) Prognostic value of coronary calciWcation and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol 27:285-290 (Pubitemid 26045496)
22. Bellasi A, Lacey C, Taylor AJ, Raggi P, BudoV MJ, Shaw LJ (2007) Comparison of prognostic usefulness of coronary artery calcium in men versus women (results from a meta-and pooled analysis estimating all-cause mortality and coronary heart disease death or myocardial infarction). Am J Cardiol 100:409-414 (Pubitemid 47094687)
23. Greenland P, Bonow RO, Brundage BH, BudoV MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP, Shaw LJ, Taylor AJ, Weintraub WS (2007) ACCF/AHA 2007 Clinical expert consensus document on coronary artery calcium scoring by computed tomography in global risk assessment and in evaluation of patients with chest pain. Circulation 115(3):402-426
24. Von Feldt JM, Eisner ER, Sawaires A (2002) Coronary electron beam computed tomography in 13 patients with systemic lupus erythematosus and 2 or more cardiovascular risk factors. J Clin Rheumatol 8:316-321 (Pubitemid 35453598)
25. Kiani AN, Magder LS, Petri M (2008) Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors but not with disease activity. J Rheumatol 35:1300-1306 (Pubitemid 352000774)
26. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar S, Rembold CM, Post WS (2008) Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force. J Am Soc Echocardiog 21(2):93-111 (Pubitemid 351193107)
27. Furberg CD, Adams HP Jr, Applegate WB, Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group (1994) Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 90:1679-1687 (Pubitemid 24320914)
28. Crouse JR III, Byington RP, Bond MG (1995) Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 75:455-459
29. Maksimowicz-McKinnon K, Magder LS, Petri M (2006) Predictors of carotid plaque in systemic lupus erythematosus. J Rheumatol 33:2458-2463 (Pubitemid 46067826)
30. Manzi S, Kuller LH, Edmundowicz D, Sutton-Tyrrell K (2000) Vascular imaging: changing the face of cardiovascular research. Lupus 9:176-182 (Pubitemid 30199259)
31. Sato H, Miida T, Narita I, Nakano M, Gejyo F (2007) Atherosclerosis is accelerated in patients with long term well controlled systemic lupus erythematosus. Clin Chim Acta 385:35-42 (Pubitemid 47376930)
32. de Leeuw K, Freire B, Smit AJ, Bijl M (2006) Traditional and nontraditional risk factors contribute to the development of atherosclerosis in patients with systemic lupus erythematosus. Lupus 15:675-682 (Pubitemid 44682830)
33. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP, OC-SELENA Trial (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353:2550-2558 (Pubitemid 41785892)
34. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A (1996) The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363-369 (Pubitemid 26085211)
35. BudoV MJ, Georgiou D, Brody A, Agatston AS, Kennedy J, Wolfkiel C (1996) Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter disease: a multicenter study. Circulation 93:898-904 (Pubitemid 26074826)
36. Bots ML, Mulder PG, Hofman A (1994) Reproducibility of carotid vessel wall thickness measurements: the Rotterdam study. J Clin Epidemiol 47:921-930 (Pubitemid 24268897)
37. Smilde TJ, Wollersheim H, Van Langen H (1997) Reproducibility of ultrasonographic measurements of diVerent carotid and femoral artery segments in healthy subjects and in patients with increased intima-media thickness. Clin Sci 93:317-324 (Pubitemid 27464294)
38. Nguyen PT, Coche E, GoYn E, Beguin C, Vlassenbroek A, Devuyst O, Robert A, Jadoul M (2007) Prevalence and determinants of coronary and aortic calciWcations assessed by chest CT in renal transplant recipients. Am J Nephrol 27:329-335 (Pubitemid 47077196)